This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2004 Nov;30(7):661-4.

doi: 10.1016/j.ctrv.2004.08.003.

Adjuvant chemotherapy with uracil-tegafur prolongs overall survival in people with primary adenocarcinoma of the lung

W K Bill Evans¹

Affiliations

PMID: 15531399
DOI: 10.1016/j.ctrv.2004.08.003

Comment

Adjuvant chemotherapy with uracil-tegafur prolongs overall survival in people with primary adenocarcinoma of the lung

W K Bill Evans. Cancer Treat Rev. 2004 Nov.

. 2004 Nov;30(7):661-4.

doi: 10.1016/j.ctrv.2004.08.003.

Author

W K Bill Evans¹

Affiliation

¹ Cancer Care Ontario, c/o 620 University Avenue, Toronto, Ontario M5G 2L7, Canada. bill.evans@cancercare.on.ca

PMID: 15531399
DOI: 10.1016/j.ctrv.2004.08.003

No abstract available

PubMed Disclaimer

Comment on

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung.
Kato H, Ichinose Y, Ohta M, Hata E, Tsubota N, Tada H, Watanabe Y, Wada H, Tsuboi M, Hamajima N, Ohta M; Japan Lung Cancer Research Group on Postsurgical Adjuvant Chemotherapy. Kato H, et al. N Engl J Med. 2004 Apr 22;350(17):1713-21. doi: 10.1056/NEJMoa032792. N Engl J Med. 2004. PMID: 15102997 Clinical Trial.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science